ReviewVeterinary research communications2026
Mammaliicoccus sciuri as a sentinel for antimicrobial resistance and virulence: genomic epidemiology, transmission dynamics, and control in the one health era.
Review in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mammaliicoccus sciuri (M. sciuri), a Gram-positive bacterium belonging to the group of coagulase-negative staphylococci (CoNS), has been taxonomically reclassified from the genus Staphylococcus to the newly established genus Mammaliicoccus. Its adaptability across diverse niches supports its relevance to One Health. Widely distributed in livestock and diverse environments, M. sciuri has been increasingly reported as an opportunistic pathogen and genetic reservoir for antimicrobial resistance (AMR) and virulence determinants of relevance to human and veterinary medicine. This review provides a synthesis of existing literature regarding the epidemiology, ecological niches, clinical relevance of the M. sciuri species, as well as the genomic and genetic features that underpin its contribution to the dissemination of resistance and virulence factors. Furthermore, it examined the global spread of methicillin-resistant M. sciuri (MR-M. sciuri) clones, characterized through phylogenetic analyses, sequence types (STs), and their complex transmission dynamics. The molecular basis of its resistance mechanisms is explored, with attention directed toward the genetic environments surrounding the mecA and mecC genes within the SCCmec cassettes, as well as the involvement of mobile genetic elements and heavy metal resistance systems. The genetic repertoire of M. sciuri, including the presence of CRISPR–Cas systems associated with adaptive immunity and genome plasticity, was also examined. Moreover, the review delves into the duality of M. sciuri as it can produce antimicrobials such as bacteriocins, which are active against bacteria and fungi. Finally, this review outlines control strategies, including genomic surveillance and stricter antimicrobial regulations, to address MDR M. sciuri strains in the human-animal-environment interface.
Indexed as
Identifiers
41870761What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.